In Vivo Gene Therapy Delivery Procedure and Device

Patent metadata

Field	Value
Publication number	US-2023074581-A1
Application number	US-202217987578-A
Country	US
Kind code	A1
Filing date	Nov 15, 2022
Priority date	Jul 24, 2018
Publication date	Mar 9, 2023
Grant date	—

Abstract

A “localizable” systemic gene therapy system is provided substantially increasing the transfection efficiency of the gene vectors into targeted tissue cells and substantially reducing the escape of the gene vectors from the targeted tissue volume, such as would waste the vectors, promote undesired immune reactions, and/or incur prohibitive costs for the required dose of gene-containing virus vectors. In this regard, the invention provides a means to simultaneously achieve local electroporation and gene-containing vector injection in a portion of a vascularized organ. It includes two double-balloon catheters that create contained volumes in parallel blood vessels for the introduction of vectors with reduced loss along with electrodes providing electroporation of the cells in the same location where the vectors are injected.

First claim

What we claim is:

1 . A gene delivery system for delivering viral vectors containing genetic material into cells of a patient, comprising:
a first electrode insertable into a first blood vessel of the patient; a second electrode insertable into a second blood vessel of the patient; and an electric pulse generator configured to deliver at least one electric pulse to at least one of the first and second electrodes to apply a voltage between the first and second electrodes and create an electric field across the first and second electrodes and on cells surrounding the electrodes to increase the transduction rate of viral vectors into the cells of the patient.

2 . The system of claim 1 further comprising
a first catheter comprising a distal end defining a delivery portion and at least one passageway through a lumen of the catheter for the delivery of at least one viral vector wherein the first electrode extends along the first catheter; and
a second catheter comprising a distal end defining a delivery portion and at least one passageway through a lumen of the catheter for the delivery of at least one viral vector wherein the second electrode extends along the second catheter.

3 . The system of claim 1 wherein the at least one electrical pulse is configured to produce an electric field strength between the first and second electrode and a pulse duration that increases the delivery of viral vectors into cells surrounding the electrodes according to a processor executing a program held in stored memory.

4 . The system of claim 3 wherein the at least one electrical pulse is configured to produce an electric field strength between the first and second electrode that is 100-200 V/cm.

5 . The system of claim 4 wherein the at least one electrical pulse has a pulse duration of 38-100 msec.

6 . The system of claim 3 wherein the at least one electrical pulse is configured to produce an electric field strength between the first and second electrode that is 200-275 V/cm.

7 . The system of claim 6 wherein the at least one electrical pulse has a pulse duration of about 50 msec.

8 . The system of claim 3 wherein the shape of the electric pulse and number of pulses of the electrical charge are configured to produce an electric field increasing the delivery of viral vectors into the cells surrounding the first and second electrodes according to a processor executing a program held in stored memory.

9 . The system of claim 1 wherein the at least one viral vector contains foreign, functional genes.

10 . A method for delivering one or more viral vectors containing genetic material into cells of a patient, comprising:
inserting a first electrode into a first blood vessel of the patient; inserting a second electrode into a second blood vessel of the patient; injecting the at least one viral vector into the patient; and delivering at least one electrical pulse to at least one of the first and second electrodes configured to apply a voltage between electrodes and create an electric field across the first and second electrodes and on cells surrounding the electrodes to increase the transduction rate of viral vectors into the cells surrounding the electrodes of the patient.

11 . The method of claim 10 further comprising
providing a first catheter comprising a distal end to define a delivery portion, at least one passageway through a lumen of the catheter for the delivery of the at least one viral vector through the delivery portion, and a proximal end having a therapeutic injection port;
inserting the first catheter into the first blood vessel of the patient;
providing a second catheter comprising a distal end to define a delivery portion, at least one passageway through a lumen of the catheter for the delivery of at least one viral vector through the delivery portion, and a proximal end having a therapeutic injection port; and
inserting the second catheter into the second blood vessel of the patient.

12 . The method of claim 10 wherein the at least one electrical pulse is configured to produce an electric field strength between the first and second electrode and a pulse duration that increases the delivery of viral vectors into the cells surrounding the first and second electrodes according to a processor executing a program held in stored memory.

13 . The method of claim 12 wherein the at least one electric pulse is configured to produce an electric field strength between the first and second electrode that is 100-200 V/cm.

14 . The method of claim 13 wherein the at least one electrical pulse has a pulse duration of 38-100 msec.

15 . The method of claim 12 wherein the at least one electric pulse is configured to produce an electric field strength between the first and second electrode that is 200-275 V/cm.

16 . The system of claim 15 wherein the at least one electrical pulse has a pulse duration of about 50 msec.

17 . The method of claim 10 wherein the at least one viral vector delivers foreign, functional genes into the cells of the patient.

18 . The method of claim 10 wherein the first and second electrodes are inserted into first and second blood vessels located within a vascularized organ, tissue, or tumor.

19 . The method of claim 18 wherein the first and second electrodes are inserted into first and second blood vessels located in a liver of the patient.

Assignees

• Wisconsin Alumni Res Found

Inventors

• Hagness Susan
• Aiken Erik
• Booske John
• Sollinger Hans
• Laeseke Paul
• Alam Tausif

Classifications

• A61M2025/1052

  for temporarily occluding a vessel for isolating a sector · CPC title

• A61N1/306

  Arrangements where at least part of the apparatus is introduced into the body · CPC title

• A61N1/325 Primary

  for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body (electrodes for external use A61N1/0428) · CPC title

• A61M31/00

  Devices for introducing or retaining media, e.g. remedies, in cavities of the body (A61M25/00 takes precedence {; introducing or retaining ophthalmic products into the ocular cavities A61F9/0008}) · CPC title

• A61K48/0075

  characterised by an aspect of the delivery route, e.g. oral, subcutaneous · CPC title